4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aardvark Therapeutics, Inc. (AARD) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 40 employees. Its market capitalization is roughly $138 million. In the fiscal year ended 2025-12-31, AARD reported $0M in revenue and ($58M) in net income.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($63M) | ($23M) | ($7M) | ($11M) |
| Net Income | ($58M) | ($21M) | ($7M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($22M) | ($19M) | ($18M) | ($16M) | ($10M) | — |
| Net Income | ($22M) | ($18M) | ($16M) | ($14M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $117M | $78M | $10M | $17M |
| Total Liabilities | $10M | $132M | $45M | $45M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AARD viewer.
About TickerBase · Data methodology & sources